Beacon Financial Strategies’s Precision BioSciences DTIL Stock Holding History

Beacon Financial Strategies’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Hold	172	–	–	﹤0.01%	197
2026 Q1	$946	Hold	172	–	–	﹤0.01%	170
2025 Q4	$716	Buy	+172	New	+$976	﹤0.01%	180

Other funds holding DTIL

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

Beacon Financial Strategies's DTIL Position: Q2 2026 in Review

Beacon Financial Strategies held its Precision BioSciences (DTIL) position steady in Q2 2026 at 172 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #197.

Beacon Financial Strategies first reported a position in DTIL in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Beacon Financial Strategies held 172 shares of Precision BioSciences worth $1.35K as of Q2 2026.
Beacon Financial Strategies left its Precision BioSciences share count unchanged in Q2 2026.
Precision BioSciences made up ﹤0.01% of Beacon Financial Strategies's portfolio in Q2 2026, its #197 holding.
Beacon Financial Strategies first reported a position in Precision BioSciences in Q4 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Beacon Financial Strategies's 13F filing for Q2 2026, filed 8 Jul 2026.